Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?

To: Dr. John M. de Castro who wrote (602)	3/4/1999 6:09:00 PM
From: Tony van Werkhooven	Read Replies (1) \| Respond to of 1386

John- Your interpretation is what I would also have come up with. Another interesting sentence attributed to Bob Cook: <1999 is the year we move closer to becoming a profitable operating company.> I assume that this means that Bob Cook projects 1999 to also have a loss. Would be intresting to ask Bob for further comments. Tony

To: Dr. John M. de Castro who wrote (602)	3/4/1999 8:35:00 PM
From: Omer Shvili	Read Replies (2) \| Respond to of 1386

John, Your interpretation about "gearing up for PIII" is quite correct. PARS has been doing a lot of work for the upcoming PIII HU211 trials. Anything PARS can do without a partner, is being done. Meaning, all of the preliminary work (talks with FDA, design of study etc.). This is being done in order to shorten the waiting period between signing a partner and the actual start of PIII. Another important part of the Q4 press release, is the fact that there were still inventory draw-downs at distributors during the quarter (that's the question I kept asking the company, the minute they announced sales levels). I also understand there were still some samples during Q4 (much less than in Q3). All these should decline dramatically in Q1, so revenues in Q1 will be more revealing of the true story, and of how BOL is advancing. I believe we'll see very strong growth in Q1 and the following quarters. Omer